// App-Quantinova.ai

3569 : Outcome and Toxicities of Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy Used in the Treatment of Acute Lymphoblastic Leukemia in Adolescent and Young Adult Patients, Single Center Experience From Saudi Arabia

Researchers

Presenter

  • Anas Merdad

Principal Investigators

  • Mona Al-Dabbagh

  • Ahmed Almohanad Absi

  • Ahmad Alsaeed

  • Ihab El-Hemaidi

Medical Centers

  • Pediatrics, King Abdulaziz Medical City, Jeddah, Saudi Arabia

  • Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

  • Adult Hematology/BMT, Princess Noorah Oncology Center, Jeddah, Saudi Arabia

Locations

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Venous thrombosis

  • Neutropenia

  • T-cell acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved